Mark L. Smythe
Chief Executive Officer at Infensa Bioscience Pty Ltd.
Profile
Mark L.
Smythe is the founder of Protagonist Therapeutics, Inc. which was founded in 2006.
He held the title of Vice President-Technology from 2013 to 2022.
Currently, he is the Chief Executive Officer at Infensa Bioscience Pty Ltd.
since 2022.
He previously worked at GSK Plc as a Principal.
Dr. Smythe obtained a doctorate from the University of Melbourne and an undergraduate degree from James Cook University.
Mark L. Smythe active positions
| Companies | Position | Start |
|---|---|---|
| Infensa Bioscience Pty Ltd. | Chief Executive Officer | 2022-04-30 |
Former positions of Mark L. Smythe
| Companies | Position | End |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Founder | 2022-04-30 |
| GSK PLC | Corporate Officer/Principal | - |
Training of Mark L. Smythe
| University of Melbourne | Doctorate Degree |
| James Cook University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GSK PLC | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
| Infensa Bioscience Pty Ltd. |
- Stock Market
- Insiders
- Mark L. Smythe
